Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07786077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07786077 · ClinicalTrials.gov record · last posted 2026-08-25

A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

Name: A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment — clinical trial record (NCT07786077)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorNovartis Pharmaceuticals

Started2025-12-08

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study aims to evaluate treatment preferences of patients with Primary Immune Thrombocytopenia (ITP) in the United States (US) by conducting a preference elicitation survey.

Trial Details

NCT Number	NCT07786077
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Primary Immune Thrombocytopenia
Enrollment	100 participants
Start Date	2025-12-08
Primary Completion	2026-12-15 (estimated)
Study Completion	2026-12-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-25